Reverse transcriptase inhibitors as a novel therapeutic approach for neurological autoimmune disorders

  • Post author:
  • Post category:

Research Objective We found that approved anti-retroviral drugs could stop inflammation and block neurodegeneration. We propose to validate the re-purpose efficacy of these clinically-approved retroviral drugs. Impact We have identified…

Continue ReadingReverse transcriptase inhibitors as a novel therapeutic approach for neurological autoimmune disorders

Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy.

  • Post author:
  • Post category:

Translational Candidate Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy. Area of Impact Non-destructive treatment option for drug-resistant focal epilepsy…

Continue ReadingDevelopment of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy.

A high quality, accessible cell therapy for Parkinson’s Disease produced in a scalable bioreactor system for 3D cell expansion and differentiation

  • Post author:
  • Post category:

Translational Candidate Human pluripotent stem cell expanded and differentiated dopaminergic precursor cells to treat Parkinson’s Disease at high quantity and high quality Area of Impact This candidate uses a 3D…

Continue ReadingA high quality, accessible cell therapy for Parkinson’s Disease produced in a scalable bioreactor system for 3D cell expansion and differentiation

Development of a human stem cell-derived inhibitory neuron therapeutic for the treatment of chronic focal epilepsy

  • Post author:
  • Post category:

Translational Candidate A cellular therapeutic comprised of inhibitory nerve cells produced from human stem cells Area of Impact Drug-resistant chronic temporal lobe epilepsy Mechanism of Action The product candidate is…

Continue ReadingDevelopment of a human stem cell-derived inhibitory neuron therapeutic for the treatment of chronic focal epilepsy

PRPE-SF, polarized hESC-derived RPE Soluble Factors, as a Therapy for Early Stage Dry Age-related Macular Degeneration

  • Post author:
  • Post category:

Translational Candidate PRPE-SF is a preparation of soluble factors from polarized retinal pigment epithelial cells, to support survival of photoreceptors in dry AMD (dAMD). Area of Impact dAMD with early…

Continue ReadingPRPE-SF, polarized hESC-derived RPE Soluble Factors, as a Therapy for Early Stage Dry Age-related Macular Degeneration